Exercise Dose and Aerobic Fitness Response in Alzheimer's Dementia: Findings from the FIT-AD Trial

Dereck Salisbury,Michelle A. Mathiason,Fang Yu
DOI: https://doi.org/10.1055/a-1639-2307
2022-01-01
International Journal of Sports Medicine
Abstract:The purpose of this study was to examine the effects of a 6-month cycling aerobic exercise intervention on cardiorespiratoryfitness and the dose-response relationship in community-dwelling older adults with mild-to-moderate Alzheimer's dementia. The FIT-AD trial was a single blind, 2-parallel group, pilot randomized controlled trial. The aerobic exercise group participated in a 6-month, thrice weekly, moderate-vigorous intensity cycling intervention while control group performed stretching. Card iorespiratory fitness was evaluated by peak oxygen consumption from cardiopulmonary exercise test and peakwalking distance from the shuttle walktest and 6-minute walktest. Aerobic exercise dose was calculated using the novel heart rate physical activity score. The aerobic exercise group significantly increased peak oxygen consumption (1.28 ml/kg/ min; p =0.03) in subgroup who achieved maximal criteria on cardiopulmonary exercise test. Changes in peak oxygen consumption and peak walking distance on the shuttle walk and 6-m inute walktests did not significantly differ between aerobic exercise and stretching groups. Notably, the aerobic exercise dose was strongly and significantly correlated to change in peak oxygen consumption (r= 0.60; n =16; p = 0.01), in subset who met maximal test criteria. Emphasis on exercise dose is needed in aerobic exercise programs to maximize cardiorespiratory fitness gains in persons with mild-moderate Alzheimer's dementia.
What problem does this paper attempt to address?